Day: May 29, 2025

Form 8.3 – [GLOBALDATA PLC – 28 05 2025] – (CGWL)

Written by Customer Service on May 29, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree GLOBALDATA PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Form 8.3 – [CRANEWARE PLC – 28 05 2025] – (CGWL)

Written by Customer Service on May 29, 2025. Posted in Mergers And Acquisitions.

FORM 8.3 PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORERule 8.3 of the Takeover Code (the “Code”) 1. KEY INFORMATION(a) Full name of discloser: CANACCORD GENUITY WEALTH LIMITED (for Discretionary clients)(b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c) Name of offeror/offeree in relation to whose relevant securities this form relates: Use a separate form for each offeror/offeree CRANEWARE PLC(d) If an exempt fund manager connected with an offeror/offeree, state this and specify identity of offeror/offeree: N/A(e) Date position held/dealing...

Zenas BioPharma to Present at the Jefferies Global Healthcare Conference

Written by Customer Service on May 29, 2025. Posted in Public Companies.

WALTHAM, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in the development and commercialization of therapies for autoimmune diseases, today announced management’s presentation at the Jefferies Global Healthcare Conference on Thursday, June 5, 2025, at 1:25 p.m. ET. A live webcast and archived replay of the Company’s presentation can be accessed under “Events and Presentations” in the Investor & Media Relations section of the Zenas BioPharma website. About Zenas BioPharma, Inc.Zenas is a clinical-stage global biopharmaceutical company committed to becoming a leader in the development and commercialization of transformative therapies for patients with autoimmune diseases. Our core business strategy...

uniQure Presents Clinical Case Study of First Patient Dosed with AMT-260 in Refractory Mesial Temporal Lobe Epilepsy (MTLE)

Written by Customer Service on May 29, 2025. Posted in Public Companies.

~ No serious adverse events and 92% reduction in seizure frequency observed in the first trial participant through first five months of follow up ~ ~ Data to be presented today at Epilepsy Therapies & Diagnostics Development Symposium (ETDD) ~ LEXINGTON, Mass. and AMSTERDAM, May 29, 2025 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced the presentation of a clinical case study of the first participant dosed in the first cohort of its ongoing Phase I/IIa trial of an investigational gene therapy candidate, AMT-260, in patients with refractory MTLE. The data are being presented today, May 29, 2025 by Firas Taha, M.D., Medical Director, Clinical Development at uniQure, at the Epilepsy Therapies & Diagnostics...

Axsome Therapeutics to Participate in Upcoming Investor Conferences

Written by Customer Service on May 29, 2025. Posted in Public Companies.

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) — Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) disorders, today announced that it will participate in three upcoming investor conferences in June:William Blair 45th Annual Growth Stock ConferenceThe Company will present on Tuesday, June 3, 2025, at 10:40 a.m. CT in Chicago, ILJefferies Global Healthcare ConferenceThe Company will present on Thursday, June 5, 2025, at 2:35 p.m. ET in New York, NYGoldman Sachs 46th Annual Global Healthcare ConferenceThe Company will present on Monday, June 9, 2025, at 2:40 p.m. ET in Miami Beach, FLLive webcasts of the presentations can be accessed on the “Webcasts & Presentations” page of the “Investors” section of the Company’s website at axsome.com....

FactSet Schedules Third Quarter 2025 Earnings Call

Written by Customer Service on May 29, 2025. Posted in Public Companies.

NORWALK, Conn., May 29, 2025 (GLOBE NEWSWIRE) — FactSet (NYSE: FDS | NASDAQ: FDS), a global financial digital platform and enterprise solutions provider, today announced it will release its financial and operating results for the third quarter fiscal 2025, ending May 31, 2025, on Monday, June 23, 2025. FactSet will also host a conference call to discuss these results at 9:00 a.m. Eastern Time on Monday, June 23, 2025. The following information is provided for investors who would like to participate in the conference call: Third Quarter Fiscal 2025 Conference Call DetailsDate Monday, June 23, 2025 Time: 9:00 a.m. Eastern Time Participant Registration: FactSet Q3 2025 Earnings Call Registration Please register for the conference call using the above link in advance of the call start time. The conference...

Syndax Announces Participation in June Investor Conferences

Written by Customer Service on May 29, 2025. Posted in Public Companies.

NEW YORK, May 29, 2025 (GLOBE NEWSWIRE) — Syndax Pharmaceuticals (Nasdaq: SNDX), a commercial-stage biopharmaceutical company advancing innovative cancer therapies, today announced that Michael A. Metzger, Chief Executive Officer of Syndax, as well as members of the Syndax management team, will participate in the following upcoming investor conferences:Jefferies Global Healthcare Conference with a fireside chat on Thursday, June 5, 2025, at 1:25 p.m. ET. Goldman Sachs 46th Annual Global Healthcare Conference with a fireside chat on Wednesday, June 11, 2025, at 2:00 p.m. ET.A live webcast of the fireside chats will be available in the Investor section of the Company’s website at www.syndax.com, where a replay will also be available for a limited time. About Syndax Syndax Pharmaceuticals is a commercial-stage biopharmaceutical...

Dorman’s Light Duty automotive segment announces more first-to-aftermarket repair solutions

Written by Customer Service on May 29, 2025. Posted in Public Companies.

COLMAR, Pa., May 29, 2025 (GLOBE NEWSWIRE) — The Light Duty business segment of Dorman Products, Inc. (NASDAQ:DORM) is announcing the release of hundreds of new automotive repair solutions this month, many of which are first-to-the-aftermarket products. These products join a growing Dorman catalog of over 138,000 SKUs. They offer approximately 12+ million new sales opportunities for aftermarket parts distributors, retailers and repair shops, and more accessible solutions for vehicle owners. May’s highlights include:A smart junction box for select aging Dodge Dakota pickup trucks, manufactured to help restore malfunctioning electrical equipment to factory specifications an aftermarket-exclusive automatic transmission oil cooler designed to match the performance of the original equipment unit on select Ford Super Duty trucks, adding...

Whitestone REIT to Present at Nareit’s REITweek 2025 Investor Conference

Written by Customer Service on May 29, 2025. Posted in Public Companies.

HOUSTON, May 29, 2025 (GLOBE NEWSWIRE) — Whitestone REIT (NYSE: WSR) (“Whitestone” or the “Company”) today announced that CEO Dave Holeman will participate in a “Fireside Chat” at Nareit’s 2025 REITweek Investor Conference. Mr. Holeman will be hosted by Truist Analyst Anthony Hau. When: Tuesday, June 3, 2025 at 9:30 EasternLink to Audio: https://ir.whitestonereit.com/corporate-profile/default.aspx About Whitestone REIT Whitestone REIT (NYSE: WSR) is a community-centered real estate investment trust (REIT) that acquires, owns, operates, and develops open-air, retail centers located in some of the fastest growing markets in the country: Phoenix, Austin, Dallas-Fort Worth, Houston and San Antonio. Our centers are convenience focused: merchandised with a mix of service-oriented tenants providing food (restaurants and grocers), self-care...

Kymera Therapeutics to Participate in Upcoming June Investor Conferences

Written by Customer Service on May 29, 2025. Posted in Public Companies.

WATERTOWN, Mass., May 29, 2025 (GLOBE NEWSWIRE) — Kymera Therapeutics, Inc. (NASDAQ: KYMR), a clinical-stage biopharmaceutical company advancing a new class of oral small molecule degrader medicines for immunological diseases, today announced that the Company will participate in fireside chats at the following upcoming investor events: Jefferies Global Healthcare Conference in New York, NY on June 5 at 8:10 a.m. ET; Goldman Sachs 46th Annual Global Healthcare Conference in Miami, FL on June 10 at 3:20 p.m. ET; and Wolfe Research Virtual Biotech Day on June 26, one-on-one meetings only.Live webcasts of the presentations will be available under “News and Events” in the Investors section of the Company’s website at www.kymeratx.com. Replays of the webcasts will be archived and available following the events. About Kymera Therapeutics Kymera...

Day: May 29, 2025

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals